Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Pass Above Two Hundred Day Moving Average – Here’s What Happened

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)’s share price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.53 and traded as high as $2.84. Cumberland Pharmaceuticals shares last traded at $2.53, with a volume of 67,860 shares.

Analysts Set New Price Targets

Separately, StockNews.com started coverage on shares of Cumberland Pharmaceuticals in a research note on Tuesday. They set a “hold” rating on the stock.

Cumberland Pharmaceuticals Trading Down 8.7 %

The company’s 50-day moving average is $1.90 and its 200-day moving average is $1.53. The stock has a market capitalization of $35.52 million, a price-to-earnings ratio of -3.29 and a beta of 0.13. The company has a quick ratio of 0.99, a current ratio of 1.13 and a debt-to-equity ratio of 0.41.

Cumberland Pharmaceuticals Company Profile

Cumberland Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.